PROSTAGLANDIAN BIOLOGY IN INFLAMMATORY BOWEL DISEASE

This publication has 46 references indexed in Scilit:

• Selective COX‐2 inhibitors and human inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 1999
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats
  British Journal of Pharmacology, 1998
• Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
  Drug Development Research, 1992
• Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.
  The Journal of Experimental Medicine, 1991
• Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan-polysaccharide polymers
  Inflammation Research, 1989
• Prostaglandin protection of rat colonic mucosa from damage induced by ethanol
  Digestive Diseases and Sciences, 1985
• Arachidonic acid metabolites regulate interleukin-1 production
  Biochemical and Biophysical Research Communications, 1985
• Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
  Gut, 1980
• Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.
  Gut, 1978
• INCREASED PROSTAGLANDIN PRODUCTION IN ULCERATIVE COLITIS
  The Lancet, 1977